Halozyme Therapeutics, Inc. (HALO)

Last Three Months

26-Aug-24 -- 25-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

37

0

0

+1

0

+2

0

+3

Two Year Chart

26-Nov-22 -- 25-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
09-Oct-24 5:39 PM View:	09-Oct-24 Planned Option Sale ($525.78K)	Torley Helen President and CEO Director		Halozyme Therapeutics, Inc. - HALO	0% 676.74K	0	0	--	--	Show Txns Hide Txns

16-Oct-24 6:53 PM View:	16-Oct-24 Planned Option Sale ($532.59K)	Labarre Michael J. SVP, Chief Technical Officer		Halozyme Therapeutics, Inc. - HALO	3% 168.18K to 173.76K	0	0	--	--	Show Txns Hide Txns